VERO BIOTECH, INC. drugs

3 results

  • genosyl

    (nitric oxide)
    VERO BIOTECH, INC.
    GENOSYL® is indicated to improve oxygenation and decrease the need for extracorporeal membrane oxygenation in term and near-term neonates (over 34 weeks gestation) experiencing hypoxic respiratory failure due to pulmonary hypertension, in conjunction with ventilatory support and other appropriate treatments.
    Medication Details

  • genosyl

    (nitric oxide)
    VERO BIOTECH, INC.
    GENOSYL® is indicated for improving oxygenation and decreasing extracorporeal membrane oxygenation needs in term and near-term neonates with hypoxic respiratory failure and pulmonary hypertension, when used alongside ventilatory support and other appropriate treatments.
    Medication Details